NewTradingView.com – Investing and Stock News
Investing and Stock News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Editor's Pick

Trump offers to release his October MRI results, insists scan wasn’t of his brain

by December 1, 2025
written by December 1, 2025

President Donald Trump told reporters aboard Air Force One Sunday that he would release the results of an MRI he had done in October.

‘If they want to release it, it’s OK with me to release it,’ Trump said. ‘It’s perfect.’ 

‘If you want to have it released, I’ll release it,’ he told reporters as he traveled back to Washington, D.C., after spending the Thanksgiving weekend at Mar-a-Lago.

A reporter asked Trump what part of the body the MRI was focused on in the scan.

‘I have no idea,’ the president responded. ‘What part of the body? It wasn’t the brain because I took a cognitive test and I aced it. I got a perfect mark.’

The White House released a memo on Oct. 10 from Sean Barbabella, the White House physician, that said Trump underwent advanced imaging as part of a scheduled follow-up evaluation at Walter Reed National Military Medical Center.

Barbabella said the evaluation was part of the president’s ongoing health maintenance plan and included laboratory testing and preventive health assessments.

‘Comprehensive laboratory studies performed in conjunction with the visit were exceptional, including stable metabolic, hematologic, and cardiac parameters,’ the memo read in part.

A reporter previously asked White House press secretary Karoline Leavitt in early November at a White House press briefing about releasing the results of the MRI because it is a very specific procedure and not generally routine. 

‘As I said, I’ll check back for you,’ Leavitt responded.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump says he believes Hegseth ‘100%’ on Venezuelan drug boat strike denial amid allegations
next post
NATO considers ‘more aggressive’ response to Russia’s hybrid threats

You may also like

North Korea releases images of development of nuclear-powered...

December 25, 2025

Christmas Eve jazz concert canceled at Kennedy Center...

December 25, 2025

Nearly 20 states sue HHS over declaration to...

December 25, 2025

Trump-backed candidate Asfura wins Honduras presidential election

December 25, 2025

DOJ discovers more than 1M potential Epstein records,...

December 24, 2025

Here’s how the Cabinet secretaries and their families...

December 24, 2025

Here’s how the Cabinet Secretaries and their families...

December 24, 2025

MIKE DAVIS: FBI knew Mar-a-Lago raid was illegal,...

December 24, 2025

Top 5 takeaways from latest Jeffrey Epstein files...

December 24, 2025

New Trump admin envoy says US won’t ‘conquer’...

December 24, 2025
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!




    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular Posts

    • 1

      Gold and Silver: Gold remains stable in the $2420 zone

    • 2

      Oil and natural gas: Oil is back on the positive side

    • 3

      The dollar index continues to pull back to a new low

    • 4

      IonQ Stock Review: Should You Consider Investing Now?

    • 5

      Gold Price Surge Hits $3,385 Amid Trade Tensions

    Recent Posts

    • North Korea releases images of development of nuclear-powered submarine

      December 25, 2025
    • Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

      December 25, 2025
    • GLP-1 weight-loss pills set to reshape US food demand in 2026

      December 25, 2025
    • US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

      December 25, 2025
    • Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

      December 25, 2025

    Categories

    • Economy (20)
    • Editor's Pick (331)
    • Investing (134)
    • Stock (20)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: NewTradingView.com, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 NewTradingView.com All Rights Reserved.


    Back To Top
    NewTradingView.com – Investing and Stock News
    • Investing
    • Stock
    • Economy
    • Editor’s Pick